Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain Treatment for Depression in Patients With Dementia
NCT02267057Phase 4Completed
- Sponsor
- University of Bergen
- Start
- Aug 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetaminophen and buprenorphine in major depressive disorder (MDD), sponsored by University of Bergen. Primary endpoint: Cornell Scale for Depression in Dementia at Week 13. Started Aug 2014; status: completed.
02
Drugs
acetaminophenbuprenorphine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02267057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267057.